- Home
- OCC vs FGEN Comparison
OCC vs FGEN Comparison
Compare OCC & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- FGEN
- Stock Information
- Founded
- OCC 1983
- FGEN 1993
- Country
- OCC United States
- FGEN United States
- Employees
- OCC N/A
- FGEN N/A
- Industry
- OCC Telecommunications Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- FGEN Health Care
- Exchange
- OCC Nasdaq
- FGEN Nasdaq
- Market Cap
- OCC 40.9M
- FGEN 38.4M
- IPO Year
- OCC 1996
- FGEN 2014
- Fundamental
- Price
- OCC $5.32
- FGEN $11.30
- Analyst Decision
- OCC
- FGEN Strong Buy
- Analyst Count
- OCC 0
- FGEN 2
- Target Price
- OCC N/A
- FGEN $146.50
- AVG Volume (30 Days)
- OCC 74.1K
- FGEN 63.2K
- Earning Date
- OCC 09-10-2025
- FGEN 08-11-2025
- Dividend Yield
- OCC N/A
- FGEN N/A
- EPS Growth
- OCC N/A
- FGEN N/A
- EPS
- OCC N/A
- FGEN N/A
- Revenue
- OCC $68,999,601.00
- FGEN $7,346,000.00
- Revenue This Year
- OCC N/A
- FGEN N/A
- Revenue Next Year
- OCC N/A
- FGEN N/A
- P/E Ratio
- OCC N/A
- FGEN N/A
- Revenue Growth
- OCC 5.77
- FGEN N/A
- 52 Week Low
- OCC $2.02
- FGEN $4.50
- 52 Week High
- OCC $7.00
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- OCC 53.31
- FGEN 77.82
- Support Level
- OCC $5.01
- FGEN $9.05
- Resistance Level
- OCC $6.06
- FGEN $9.94
- Average True Range (ATR)
- OCC 0.54
- FGEN 0.70
- MACD
- OCC -0.09
- FGEN 0.33
- Stochastic Oscillator
- OCC 57.34
- FGEN 91.78
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.